Viatris Inc SEC filings VTRS
Viatris Inc has 542 filings in SEC EDGAR's recent list, going back to Oct 25, 2019. Its latest annual report, Form ARS, was filed on Apr 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 8, 2026 (material agreement, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Other events
|
Oct 8, 2026 | Oct 8, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Jul 1, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 18, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Other events
|
Jun 15, 2026 | Jun 12, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 15, 2026 | May 15, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 4, 2026 | May 1, 2026 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Other events
|
Feb 26, 2026 | Feb 23, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 3, 2026 | Jan 29, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 8, 2025 | Dec 8, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Dec 5, 2025 | Dec 5, 2025 |
| 8-K/A |
Amended current report
Officer or director change
|
Dec 5, 2025 | Aug 4, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Oct 24, 2025 | Oct 24, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 5, 2025 | Aug 4, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 5, 2025 | May 5, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Feb 27, 2025 | Feb 27, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Dec 6, 2024 | Dec 6, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Sep 27, 2024 | Sep 27, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 4, 2024 | Sep 4, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Acquisition or sale of assets
|
Jul 3, 2024 | Jul 3, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 3, 2024 | Jun 3, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Feb 28, 2024 | Feb 28, 2024 |
| 8-K/A |
Amended current report
Material agreement
|
Jan 30, 2024 | Oct 1, 2023 |
| 8-K/A |
Amended current report
Officer or director change
|
Dec 15, 2023 | May 19, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 15, 2023 | Dec 14, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Dec 15, 2023 | Dec 14, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 15, 2023 | Dec 15, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 7, 2023 | Nov 7, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 24, 2023 | Oct 24, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 20, 2023 | Oct 20, 2023 |
| 8-K |
Current report
Material agreement
|
Oct 2, 2023 | Oct 1, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 2, 2023 | Oct 1, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 7, 2023 | Aug 7, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 22, 2023 | May 19, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
May 8, 2023 | May 8, 2023 |
| 8-K/A |
Amended current report
Officer or director change
|
Feb 27, 2023 | Dec 28, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 27, 2023 | Feb 24, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Feb 27, 2023 | Feb 27, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 29, 2022 | Dec 28, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Dec 9, 2022 | Dec 9, 2022 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
|
Nov 29, 2022 | Nov 28, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 7, 2022 | Nov 7, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 7, 2022 | Nov 7, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 8, 2022 | Aug 8, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
May 9, 2022 | May 9, 2022 |
| 8-K |
Current report
Material agreement
|
Feb 28, 2022 | Feb 27, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Feb 28, 2022 | Feb 28, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Dec 16, 2021 | Dec 10, 2021 |
| 8-K | Current report | Nov 8, 2021 | Nov 8, 2021 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 9, 2021 | Aug 9, 2021 |
| 8-K |
Current report
Material agreement, New debt
|
Jul 1, 2021 | Jul 1, 2021 |
| 8-K |
Current report
Other events
|
Jun 17, 2021 | Jun 17, 2021 |
| 8-K |
Current report
Results of operations, Other events
|
May 10, 2021 | May 10, 2021 |
| 8-K/A |
Amended current report
Exit or restructuring costs
|
Feb 25, 2021 | Nov 16, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 22, 2021 | Feb 22, 2021 |
| 8-K/A | Amended current report | Jan 29, 2021 | Nov 16, 2020 |
| 8-K/A |
Amended current report
Exit or restructuring costs
|
Dec 11, 2020 | Nov 16, 2020 |
| 8-K |
Current report
Material agreement, Auditor change, Officer or director change
|
Nov 25, 2020 | Nov 19, 2020 |
| 8-K/A |
Amended current report
Material agreement, Agreement ended, New debt, Other events
|
Nov 19, 2020 | Nov 16, 2020 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Exit or restructuring costs, Change in control, Officer or director change, Bylaw or fiscal year change
|
Nov 19, 2020 | Nov 16, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 6, 2020 | Aug 6, 2020 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 26, 2020 | Jun 22, 2020 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 17, 2020 | Jun 16, 2020 |
| 8-K |
Current report
Material agreement
|
Jun 2, 2020 | May 29, 2020 |
| 8-K |
Current report
Results of operations, Other events
|
May 29, 2020 | May 29, 2020 |
Showing 72 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VTRS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Canonsburg, PA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1792044
- Former names
- Upjohn Inc (until Nov 10, 2020)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.